2010 Grant Awards
The posters and papers listed below each grant arise from work facilitated through the grant funding.
Evaluating Cardiac Risk in Patients with Moderate to Severe Rheumatoid Arthritis
Principal Investigator: Keeling, S(PDF)
Co-investigators: Gyenes, G; McMurtry, S; McAlistair, F
- Cardiovascular risk reduction is an important part of the regular care of inflammatory arthritis patients and should include review and modification of traditional CV risk factors in addition to “treat-to-Target” disease modification.
- Surrogate markers for cardiovascular risk such as the carotid intima media thickness measurement may be a useful tool to aid rheumatologists in risk stratifying their patients.
- Further work is need to integrate carotid IMT measurements with other tools such as national CV risk scores to create a clinically useful prediction tool in determining the true CV risk in inflammatory arthritis patients.
Presented at the 2011 American College of Rheumatology Meeting.
Presented at the 2013 Canadian Rheumatology Association meeting.
- Carotid intima-media thickness as a marker for cardiovascular risk in northern Alberta patients with rheumatoid arthritis on biologics (PDF)
- Survey of Traditional Cardiovascular Risk Factors in Patients with Moderate to Severe Rheumatoid Arthritis on Biologic Therapy (PDF)
Presented at the 2013 American College of Rheumatology Meeting.
- Stability of cIMT Over 1 Year in Biologics Patients